Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 46, 2011, Pages 18637-18642

  Staquicini, Fernanda I ^a   Cardó Vila, Marina ^a   Kolonin, Mikhail G ^a,g   Trepel, Martin ^b   Edwards, Julianna K ^a   Nunes, Diana N ^a,h   Sergeeva, Anna ^a   Efstathiou, Eleni ^a   Sun, Jessica ^a   Almeida, Nalvo F ^c   Tu, Shi Ming ^a   Botz, Gregory H ^a   Wallace, Michael J ^a   O'Connell, David J ^d   Krajewski, Stan ^e   Gershenwald, Jeffrey E ^a   Molldrem, Jeffrey J ^a   Flamm, Anne L ^a,i   Koivunen, Erkki ^a   Pentz, Rebecca D ^a,j   Dias Neto, Emmanuel ^a,h   Setubal, João C ^c   Cahill, Dolores J ^d   Troncoso, Patricia ^a   Do, Kim Ahn ^a   Logothetis, Christopher J ^a   Sidman, Richard L ^f   Pasqualini, Renata ^a   Arap, Wadih ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e BURNHAM INSTITUTE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^h A C CAMARGO CANCER CENTER   (Brazil)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j EMORY UNIVERSITY   (United States)

more..

Author keywords

Angiogenesis; Human disease; Obesity; Phage display; Tumor

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA4 INTEGRIN; APOLIPOPROTEIN E3; CATHEPSIN B; LIPOCORTIN 2; LIPOCORTIN 4; MOLECULAR MARKER; MYELOBLASTIN; PEPTIDE LIBRARY; PROHIBITIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; BIOTECHNOLOGY; BLOOD VESSEL; BONE METASTASIS; CANCER PATIENT; DRUG DISTRIBUTION; FEASIBILITY STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; METASTASIS; MOLECULE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN MICROARRAY; PROTEIN MOTIF; VASCULARIZATION; WHITE ADIPOSE TISSUE;

AMINO ACID MOTIFS; ANNEXIN A4; APOLIPOPROTEIN E3; BIOPSY; BLOOD VESSELS; BONE MARROW; CATHEPSIN B; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA4; LIGANDS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; PEPTIDE LIBRARY;

EID: 81755172919     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1114503108     Document Type: Article

References (36)

1. Barrios-Rodiles M, et al. (2005) High-throughput mapping of a dynamic signaling network in mammalian cells. Science 307:1621-1625. (Pubitemid 40354744)
2. Stelzl U, et al. (2005) A human protein-protein interaction network: a resource for annotating the proteome. Cell 122:957-968. (Pubitemid 41345212)
3. Rual JF, et al. (2005) Towards a proteome-scale map of the human protein-protein interaction network. Nature 437:1173-1178.
4. Breitkreutz A, et al. (2010) A global protein kinase and phosphatase interaction network in yeast. Science 328:1043-1046.
5. Zetter BR (1990) The cellular basis of site-specific tumor metastasis. N Engl J Med 322:605-612.
6. Risau W, Flamme I (1995) Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91. (Pubitemid 26019602)
7. Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6:273-286.
8. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W (2004) Reversal of obesity by targeted ablation of adipose tissue. Nat Med 10:625-632. (Pubitemid 38796854)
9. Staquicini FI, Pasqualini R, Arap W (2009) Ligand-directed profiling: applications to target drug discovery in cancer. Expert Opin Drug Dis 4:51-59.
10. Pasqualini R, Ruoslahti E (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380:364-366. (Pubitemid 26097120)
11. Smith GP, Scott JK (1993) Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol 217:228-257.
12. Arap W, et al. (2002) Steps toward mapping the human vasculature by phage display. Nat Med 8:121-127. (Pubitemid 34155122)
13. Zurita AJ, et al. (2004) Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res 64:435-439. (Pubitemid 38120878)
14. Pentz RD, Flamm AL, Pasqualini R, Logothetis CJ, Arap W (2003) Revisiting technical guidelines for research with terminal wean and brain-dead patients. Hastings Cent Rep 33:20-26.
15. Pentz RD, et al. (2005) Ethics guidelines for research with the recently dead. Nat Med 11:1145-1149. (Pubitemid 43093654)
16. Kolonin MG, et al. (2006) Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J 20:979-981.
17. Dias-Neto E, et al. (2009) Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis. PLoS One 4:1-11.
18. Vendruscolo M, Paci E, Dobson CM, KarplusM(2001) Three key residues form a critical contact network in a protein folding transition state. Nature 409:641-645. (Pubitemid 32154819)
19. Swairjo MA, Seaton BA (1994) Annexin structure and membrane interactions: a molecular perspective. Annu Rev Biophys Biomol Struct 23:193-213. (Pubitemid 24217367)
20. Burgoyne RD, Geisow MJ (1989) The annexin family of calcium-binding proteins. Review article. Cell Calcium 10:1-10. (Pubitemid 19050291)
21. Rose DM, Alon R, Ginsberg MH (2007) Integrin modulation and signaling in leukocyte adhesion and migration. Immunol Rev 218:126-134. (Pubitemid 47052306)
22. van Vlijmen BJ, et al. (1994) Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest 93:1403-1410.
23. Lutgens SPM, Cleutjens KB, Daemen MJ, Heeneman S (2007) Cathepsin cysteine proteases in cardiovascular disease. FASEB J 21:3029-3041. (Pubitemid 47565524)
24. Liu J, Deyoung SM, Zhang M, Dold LH, Saltiel AR (2005) The stomatin/prohibitin/ flotillin/HflK/C domain of flotillin-1 contains distinct sequences that direct plasma membrane localization and protein interactions in 3T3-L1 adipocytes. J Biol Chem 280:16125-16134. (Pubitemid 40616737)
25. Zhang J, McCrae KR (2005) Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 105:1964-1969. (Pubitemid 40731779)
26. Molldrem JJ, et al. (2000) Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 6:1018-1023.
27. Campanelli D, et al. (1990) Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med 172:1709-1715.
28. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, Rauvala H (2002) Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 62:4805-4811.
29. Ishiguro H, et al. (2005) Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development. Prostate 64:92-100. (Pubitemid 40734743)
30. +-dependent manner. Cell Mol Life Sci 67:2271-2281.
31. Lobb RR, Hemler ME (1994) The pathophysiologic role of α4 integrins in vivo. J Clin Invest 94:1722-1728.
32. Gorfu G, Rivera-Nieves J, Ley K (2009) Role of β7 integrins in intestinal lymphocyte homing and retention. Curr Mol Med 9:836-850.
33. Hatters DM, Peters-Libeu CA, Weisgraber KH (2006) Apolipoprotein E structure: insights into function. Trends Biochem Sci 31:445-454. (Pubitemid 44108662)
34. Bacher S, Achatz G, Schmitz ML, Lamers MC (2002) Prohibitin and prohibitone are contained in high-molecular weight complexes and interact with alpha-actinin and annexin A2. Biochimie 84:1207-1220. (Pubitemid 36372169)
35. Kim DH, Woods SC, Seeley RJ (2010) Peptide designed to elicit apoptosis in adipose tissue endothelium reduces food intake and body weight. Diabetes 59:907-915.
36. Uehara A, Sugawara Y, Sasano T, Takada H, Sugawara S (2004) Proinflammatory cytokines induce proteinase 3 as membrane-bound and secretory forms in human oral epithelial cells and antibodies to proteinase 3 activate the cells through proteaseactivated receptor-2. J Immunol 173:4179-4189. (Pubitemid 39280784)